Suchergebnisse - "Guaraldi, Giovanni"

PubPharm (600)

41

Long-term success for people living with HIV : A framework to guide practice

enthalten in: HIV medicine | 2023

von Lazarus, J. | Wohl, D. | Cascio, M. | +7

42

Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk : A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Waters, L. | Assoumou, L. | González-Cordón, A. | +121

43

Impact of coronavirus disease 2019 on co-morbidities in HIV

enthalten in: Current opinion in HIV and AIDS | 2023

von Guaraldi, G. | Milic, J.

44

Why we need to re-define long-term success for people living with HIV

enthalten in: HIV medicine | 2023

von Fuster-RuizdeApodaca, M. | Wohl, D. | Cascio, M. | +7

45

Prevalence, clinical course and outcomes of COVID-19 in peritoneal dialysis (PD) patients : a single-center experience

enthalten in: Clinical and experimental nephrology | 2023

von Alfano, G. | Fontana, F. | Giovanella, S. | +9

46

A call for health systems to monitor the health-related quality of life of people living with HIV

enthalten in: HIV medicine | 2023

von Lazarus, J. | Van Hout, M. | Fuster-Ruizdeapodaca, M. | +2

47

Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study

enthalten in: Viruses | 2023

von Mussini, C. | Cozzi-Lepri, A. | Meschiari, M. | +22

48

Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF : the DEBATE trial

enthalten in: Frontiers in immunology | 2023

von Cossarizza, A. | Cozzi-Lepri, A. | Mattioli, M. | +18

49

Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination

enthalten in: Frontiers in immunology | 2023

von Lo Tartaro, D. | Paolini, A. | Mattioli, M. | +17

50

Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab

enthalten in: Frontiers in immunology | 2023

von De Biasi, S. | Mattioli, M. | Meschiari, M. | +13